Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, DarioHealth Corp. reported revenue of $22M, down 17.3% year over year. Operating margin was -163.9% and net margin -186.6%, on a free-cash-flow margin of -116.7% with capital expenditure at 0.6% of revenue. Every figure is computed directly from DRIO's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $22M | -163.9% | -186.6% |
| FY2024 | $27M | -213.6% | -158.1% |
| FY2023 | $20M | -276.1% | -292.0% |
| FY2022 | $28M | -205.4% | -224.9% |
| FY2021 | $21M | -372.9% | -374.2% |
How does DRIO compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.